Routine Follow up After Total Hip Arthroplasty Prior Periacetabular Osteotomy

January 30, 2013 updated by: University of Aarhus

Routine Follow up After THA in PAO Patient

Follow up study of patients, who despite periacetabular osteotomy, need a total hip arthroplasty, to see outcome.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

40

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Denmark
      • Aarhus, Denmark, 8000
        • Orthopaedic department, Aarhus Universityhospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients, who despite a joint preserving procedure(periacetabular osteotomy PAO) ended up with a total hip arthroplasty (THA).

Description

Inclusion Criteria:

  • PAO and THA

Exclusion Criteria:

  • time since THA less than 4 yrs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
PAO, osteoarhritis, THA
Other: Routine followup
questionnaires

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Does previous PAO compromise the function of a secondary THA
Time Frame: Up to 10 years after THA surgery
To describe the radiographic status (ex. cup positioning, calcifications, signs of loosing etc) of the THA, the physical function of the THA ( Harris Hip Score), and pt reported outcome measurements (SF36 and WOMAC).
Up to 10 years after THA surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Aarhus

Investigators

  • Study Chair: Kjeld Soballe, Prof. D.Msc, Orthopedic Research Unit, Aarhus University Hospital
  • Principal Investigator: Charlotte Hartig-Andreasen, MD, Orthopedic Research Unit, Aarhus University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2012

Primary Completion (Actual)

August 1, 2012

Study Completion (Actual)

October 1, 2012

Study Registration Dates

First Submitted

March 13, 2012

First Submitted That Met QC Criteria

August 1, 2012

First Posted (Estimate)

August 6, 2012

Study Record Updates

Last Update Posted (Estimate)

January 31, 2013

Last Update Submitted That Met QC Criteria

January 30, 2013

Last Verified

January 1, 2013

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • THA after PAO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hip Dysplasia

Clinical Trials on Routine followup

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe